Experience of Applying TNF--inhibitors (Adalimumab and Etanercept) while Treating a Patient with Juvenile Arthritis and Eye Failure

The article presents a seven-year-long monitoring of a patient with juvenile arthritis and eye problems who is refractory to the standard basic immunosuppressive drugs therapy. High efficiency of both tumor necrosis factor (TNF) receptor blocker etanercept and recombinant antibody to TNF- adalimuma...

Full description

Saved in:
Bibliographic Details
Main Author: T. I. Korovkina
Format: Article
Language:Russian
Published: Union of pediatricians of Russia 2015-11-01
Series:Педиатрическая фармакология
Subjects:
Online Access:https://www.pedpharma.ru/jour/article/view/517
Tags: Add Tag
No Tags, Be the first to tag this record!